Skip to main content
Cardiff Oncology, Inc. logo

Cardiff Oncology, Inc. — Investor Relations & Filings

Ticker · CRDF ISIN · US14147L1089 LEI · 549300AHOLZBHHYFWP04 US Professional, scientific and technical activities
Open in API
Filings indexed 1,012 across all filing types
Latest filing 2024-04-25 Proxy Solicitation & In…
Country US United States of America
Listing US CRDF

About Cardiff Oncology, Inc.

https://cardiffoncology.com/

Cardiff Oncology, Inc. is a clinical-stage biotechnology company developing novel cancer therapies. The company's primary focus is on leveraging the inhibition of Polo-like kinase 1 (PLK1), a well-validated oncology drug target. Its lead drug candidate, onvansertib, is an oral PLK1 inhibitor being evaluated in clinical trials. These programs test onvansertib in combination with standard-of-care therapeutics for various cancer indications. The company's strategy is designed to target tumor vulnerabilities to overcome treatment resistance and improve clinical outcomes for patients with significant unmet medical needs.

Recent filings

Filing Released Lang Actions
DEFA14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A Proxy Statement filed with the SEC, specifically labeled as "Definitive Additional Materials" related to the Annual Meeting of Stockholders. It includes details about the meeting date, proposals to be voted on (election of directors, ratification of auditors, equity plan amendment, executive compensation advisory vote), and instructions on how to access the full proxy materials and vote. The document explicitly states it is not a ballot but a notice of availability of proxy materials. It references the availability of the Proxy Statement and the 2023 Annual Report on Form 10-K online but does not contain the full proxy statement or the annual report itself. This type of document is best classified as Proxy Solicitation & Information Statement (PSI), as it provides information to shareholders to solicit their votes for the upcoming meeting.
2024-04-25 English
ARS
Annual Report
2024-04-25 English
DEF 14A
Proxy Solicitation & Information Statement
2024-04-25 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by Cardiff Oncology, Inc. It announces the presentation of abstracts at a conference (AACR) and includes a press release as an exhibit. The document explicitly states it is a current report pursuant to the Securities Exchange Act of 1934 and does not contain financial statements or detailed financial data. It is primarily an announcement of an event and a press release, not a full financial report or earnings release. The document length is 3728 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2024-04-08 English
S-8
Regulatory Filings Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC by Cardiff Oncology, Inc. Form S-8 is used to register securities to be offered to employees under employee benefit plans, such as stock options or stock purchase plans. The text includes references to the Securities Act of 1933, registration of shares issuable upon exercise of stock options, and incorporation by reference of prior filings like the 10-K. It is not a financial report like an Annual Report (10-K) or Interim Report (IR), nor is it an earnings release or management discussion. It is a registration statement related to employee stock plans, which falls under the category of Regulatory Filings (RNS) as it is a general SEC filing that does not fit other specific categories. The document length is substantial and contains detailed legal and regulatory information typical of a registration statement. Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-03-27 English
FORM 4
Director's Dealing
2024-03-07 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.